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[1.1.1]pentanesulfonamides
Robin M. Br,[a] Patrick J. Gross,[b] Martin Nieger,[c] and Stefan Brse*[a, d]
Abstract: Herein, we present the synthesis of the bench-
stable sodium bicyclo[1.1.1]pentanesulfinate (BCP-SO2Na)
and its application in the synthesis of bicyclo[1.1.1]pentyl
(BCP) sulfones and sulfonamides. The salt can be obtained
in a four-step procedure from commercially available pre-
cursors in multigram scale without the need for column
chromatography or crystallization. Sulfinates are known to
be useful precursors in radical and nucleophilic reactions
and are widely used in medicinal chemistry. This building
block enables access to BCP sulfones and sulfonamides
avoiding the volatile [1.1.1]propellane which is favorable
for the extension of SAR studies. Further, BCP-SO2Na ena-
bles the synthesis of products that were not available
with previous methods. A chlorination of BCP-SO2Na and
subsequent reaction with a Grignard reagent provides a
new route to BCP sulfoxides. Several products were ana-
lyzed by single-crystal X-ray diffraction.
Sulfones and sulfonamides are, among other sulfur-containing
groups, common moieties in drug compounds,[1] with eletrip-
tan (1), a serotonin receptor agonist, and bosentan (2), an en-
dothelin receptor antagonist, just two of many examples (Fig-
ure 1a).[2] ‘Escaping the flatland’ is a common trend in recent
years, in which the bioisosteric replacement of planar aromatic
moieties by saturated hydrocarbons can improve pharmaco-
logical properties of drug candidates.[3] The rigid bicyclo[1.1.1]-
pentanes (BCPs) have become famous target structures in
these approaches.[4] There have been studies that have used
BCPs successfully as a replacement of benzene (Figure 1b),[5]
alkyne,[6] and tert-butyl[7] groups.
Most BCPs are accessed by radical or anionic reactions with
the strained tricyclic compound [1.1.1]propellane (5).[8] The
latter can react with Grignard reagents,[6, 9] or alkyl iodides[9a,10]
to provide aryl- and alkyl-substituted BCPs. BCP amines can be
obtained by the reaction of turbo-amides with 5.[11] Sulfur-
based functional groups allow the radical opening of 5 as well,
as shown for thiols,[12] disulfides,[13] and xanthates.[14]
However, all of these reactions require the handling of the
volatile precursor 5 and the necessity of Schlenk techniques in
the preparation. Bench-stable precursors facilitate the use of
Figure 1. a) Examples for sulfone- and sulfonamide-containing drugs. b) The
replacement of a para-substituted fluorobenzene with BCP in the g-secre-
tase inhibitor 3 led to improved pharmacological properties. c) Content of
this work.
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this interesting group and a variety of BCP amines, acids and
esters are already commercially available. Recently, Kanazawa,
Uchiyama et al. developed a gram-scale synthesis of a silabo-
rated BCP.[15] The availability of sulfur-based BCP building
blocks is still limited and therefore the broad application of
this bioisostere is prevented.[16]
Sulfinates seem to be ideal candidates for this purpose as
they are highly versatile reagents. They can be employed in
nucleophilic reactions, transition-metal catalysis or serve as
radical precursors.[17]
We, herein, report the synthesis of sodium bicyclo[1.1.1]pen-
tanesulfinate (BCP-SO2Na, 6) and the utilization of this building
block in different reactions to obtain BCP sulfones 7 and sulfo-
namides 8 (Figure 1c).
The bench-stable salt could be obtained in good yield and
purity without the need of purification by column chromatog-
raphy or crystallization (Scheme 1). In the first step, [1.1.1]pro-
pellane (5) was prepared from the commercially available pre-
cursor 9 with phenyllithium as previously described and dis-
tilled together with diethyl ether (see the Supporting Informa-
tion for details).[11a] The obtained solution was used directly to
perform a thiol addition with 10.[12] After one washing step
with NaOH-solution and removal of the solvent, pure 11 was
obtained in 79% yield from 9. The sulfide 11 was oxidized with
3-chloroperoxybenzoic acid (mCPBA), which led to formation
of 12 in 82% yield. The purity of 12 could be successfully in-
creased by changing the oxidant to oxone, yielding 72% after
extraction with dichloromethane. The sulfone 12 was convert-
ed to the respective sulfinate in a retro-Michael reaction initiat-
ed by sodium methoxide.[18] Without further purification, prod-
uct 6 was obtained in quantitative yield. The synthesis was per-
formed on a multigram-scale (9.4 g, 61 mmol) in an overall
yield of 65% (with mCPBA) or 57% (with oxone) over four
steps.
With the novel building block 6 in hand, we performed sev-
eral reactions that prove its versatility. Nucleophilic aromatic
substitutions (SNAr) resulted in good to excellent yields with
electron-deficient aryl fluorides (7a–c), while poor to fair yields
were observed with heteroaryl chlorides (7d,e) (Scheme 2a). It
should be noted that attempts to obtain heteroaryl-substituted
BCP sulfides through aromatic thiol addition to 5 were not suc-
cessful. This method is the first to provide access to heteroaryl-
containing structures, for example, 7d and 7e, to our current
knowledge.
To access BCP sulfones with aryl substituents with higher
electron density, such as 7 f, a copper(I)-catalyzed reaction was
deployed successfully (Scheme 2b). Simple alkylation with
methyl iodide (14) could be performed without the addition of
a base at low temperature (0 8C) (Scheme 2c).
Numerous procedures can be found to convert sulfinates,
isolated or in situ, into sulfonamides. For a summary of recent
methods we refer the reader to review articles by Messaoudi,
Alami and Hamze et al.[17a] and Maulide et al.[17c] For the conver-
sion of 6 into N-alkyl sulfonamides 8a,b we chose the simple
conditions by Yuan et al. (Scheme 3a).[19] This reaction enables
Scheme 1. Synthesis of sodium BCP-SO2Na (6) from commercially available
cyclopropane 9. The synthesis was performed on a multigram-scale (9.4 g,
61 mmol for method A). Oxone: 2KHSO5·KHSO4·K2SO4.
Scheme 2. Syntheses of sulfones 7 through (a) SNAr, (b) copper(I) catalysis,
and (c) alkylation. [a] Addition of 1.50 equiv of K2CO3.
Scheme 3. Syntheses of N-alkyl sulfonamides 8a,b (a) and primary sulfona-
mide 8c (b).
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access to BCP sulfonamides for the first time. Previous at-
tempts with protected BCP thiols (Bn- and TIPS-protected)
were unsuccessful as the BCP thiol seemed to rearrange
during the deprotection step and no desired product could be
detected.
The primary BCP sulfonamide 8c could be obtained in very
good yield from 6 with hydroxylamine-O-sulfonic acid
(Scheme 3b). This compound provides easy access to N-acyl
sulfonamides 16, another medicinally relevant class of com-
pounds.[20]
To further extend the possible modifications of 6, a chlorina-
tion was performed and the sulfinyl chloride 17 was reacted
with phenylmagnesium bromide in situ to obtain sulfoxide 18
(Scheme 4).
For several products, we were able to obtain single crystals
and determine the structure by X-ray diffraction (Supporting
Information). Three of those structures (7a, 7g, 8b) are shown
in Figure 2.
In conclusion, we have developed a four-step synthesis of
BCP-SO2Na (6) from commercially available precursors. The syn-
thesis is scalable and requires no chromatography or crystalli-
zation to purify the product. We have shown the application
of this building block in the syntheses of several sulfones and
sulfonamides. The synthesis of sulfoxides was shown for one
example as a proof-of-concept.
This building block will be a useful tool in novel structure–
activity-relationship studies and will expand the application of
BCPs in medicinal chemistry.
Experimental Section
Full experimental details and analytical data (1H NMR, 13C NMR, X-
ray analysis) are provided in the Supporting Information.
CCDC 1959595 (7a), 1959596 (7b), 1959597 (7c), 1959598 (7g),
and 1959599 contain the supplementary crystallographic data for
this paper. These data are provided free of charge by The Cam-
bridge Crystallographic Data Centre.
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Sodium
Bicyclo[1.1.1]pentanesulfinate: A
Bench-Stable Precursor for
Bicyclo[1.1.1]pentylsulfones and
Bicyclo-[1.1.1]pentanesulfonamides
Scaling the chemical heights! We pres-
ent a scalable synthesis of the bench-
stable sodium bicyclo[1.1.1]pentane sul-
finate (BCP-SO2Na) in four steps without
the need of chromatography or crystalli-
zation. Further, its application in the
synthesis of BCP sulfones and sulfona-
mides is described (see scheme).
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